期刊文献+

阿立哌唑治疗精神分裂症临床观察 被引量:50

Clinical study of aripiprazole in treatment of schizophrenia
暂未订购
导出
摘要 目的:探讨阿立哌唑治疗精神分裂症的疗效及安全性。方法:以阿立哌唑治疗精神分裂症30例,采用阳性与阴性症状量表(PANSS)、副反应量表(TESS)和锥体外系反应量表(ESRS)评定疗效及不良反应。疗程8周。结果:阿立哌唑治疗精神分裂症有效率86.7%,显效率60.0%,无明显锥体外系反应。结论:阿立哌唑治疗精神分裂症疗效确切,不良反应少。 Objective:To study the efficacy and side effect of aripiprazole in the treatment of schizophrenic patients. Method: Thirty schizophrenic patients were treated with aripiprazole. The efficaey was measured with the positive and negative symptoms scale (PANSS). The adverse events were determined by the treatment emergent symptoms scale (TESS) and extrapyramidal symptom rating scale (ESRS). Results:Tile efficacy rate of aripiprazole was 86.7 %, in which 60.0% were improved markedly. Extrapyramidal side effects were few. Conclusion: Aripiprazole is an effective drug for schizophrenia, with few side effects.
出处 《临床精神医学杂志》 2006年第1期46-47,共2页 Journal of Clinical Psychiatry
关键词 阿立哌唑 精神分裂症 aripiprazole schizophrenia
  • 相关文献

参考文献3

二级参考文献23

  • 1Kilkuchiet T,et al:J Pharmacol Exp Ther.1995;274(1):329—336.
  • 2Semba J,et al:Neuropharmacology,1995;34(7):785—791.
  • 3Fujikawa M,et al:Pharmacol Biochem Behav.1996;53(4):903—909.
  • 4Alison P,et al:Molecular Brain Research,1998;55:285—292.
  • 5Inoue A。et al:Brain Res Mol Brain Res.1998;55:285—292.
  • 6Shapine DA,et al:Neuropsychopharmacology,2003:1 46(5):214—216.
  • 7Bruce S:Drugs Research and Development,1999;2(1):47—48.
  • 8Stephen M,et al:Drugs oI the Future,2000;25(9):961—963.
  • 9Susman ED:Drugs oI the Future,1997;22(9):1029—1030.
  • 10McGavin JK,et al:CNS Drugs,2002;16(11):779—788.

共引文献438

同被引文献150

引证文献50

二级引证文献97

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部